We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.6B
AUM Growth
+$1.15B
(+1.6%)
Cap. Flow
-$3.6B
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
20.8%
Holding
3,102
New
50
Increased
790
Reduced
2,114
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$38.7M |
| 2 |
International Flavors & Fragrances
IFF
|
+$27.4M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$14.7M |
| 4 |
ConocoPhillips
COP
|
+$14.5M |
| 5 |
Royalty Pharma
RPRX
|
+$9.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$269M |
| 2 |
Microsoft
MSFT
|
+$172M |
| 3 |
Amazon
AMZN
|
+$114M |
| 4 |
Walt Disney
DIS
|
+$62.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$61.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.61% |
| 2 | Financials | 14.26% |
| 3 | Healthcare | 12.86% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Forrester Research
FORR
$224M
| $1.33M | ﹤0.01% |
31,389
+777
| +3% | +$33.7K |
|
|
SWCH
2077
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $1.33M | ﹤0.01% |
81,895
+3,254
| +4% | +$54.2K |
|
2078
Upland Software
UPLD
$15.4M
| $1.33M | ﹤0.01% |
2,820
-244
| -8% | -$118K |
|
2079
Zentalis Pharmaceuticals
ZNTL
$302M
| $1.33M | ﹤0.01% |
30,609
-1,848
| -6% | -$79.6K |
|
|
MODN
2080
DELISTED
MODEL N, INC.
MODN
| $1.32M | ﹤0.01% |
37,410
-3,687
| -9% | -$142K |
|
|
HAYN
2081
DELISTED
Haynes International, Inc.
HAYN
| $1.32M | ﹤0.01% |
44,388
+850
| +2% | +$22.9K |
|
|
EPZM
2082
DELISTED
Epizyme, Inc
EPZM
| $1.32M | ﹤0.01% |
151,106
-1,375
| -0.9% | -$14.2K |
|
2083
Columbia Financial
CLBK
$1.13B
| $1.31M | ﹤0.01% |
75,237
-6,724
| -8% | -$112K |
|
2084
Progyny
PGNY
$2.2B
| $1.31M | ﹤0.01% |
29,535
-3,651
| -11% | -$171K |
|
2085
Modine Manufacturing
MOD
$10.4B
| $1.31M | ﹤0.01% |
88,946
-4,790
| -5% | -$68.1K |
|
2086
Future Fuel
FF
$223M
| $1.31M | ﹤0.01% |
90,349
+3,531
| +4% | +$52.1K |
|
|
COWN
2087
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $1.3M | ﹤0.01% |
37,023
-4,727
| -11% | -$152K |
|
|
ONT
2088
Onterris Inc
ONT
$580M
| $1.3M | ﹤0.01% |
25,879
+13,404
| +107% | +$566K |
|
2089
Scholar Rock
SRRK
$6.44B
| $1.3M | ﹤0.01% |
25,605
-1,569
| -6% | -$86.8K |
|
2090
Independent Bank Corp
IBCP
$844M
| $1.29M | ﹤0.01% |
54,400
-10,334
| -16% | -$219K |
|
2091
Douglas Dynamics
PLOW
$1.02B
| $1.28M | ﹤0.01% |
27,734
-2,516
| -8% | -$116K |
|
2092
ADT
ADT
$5.58B
| $1.28M | ﹤0.01% |
151,526
+3,136
| +2% | +$27.2K |
|
|
CONN
2093
DELISTED
Conn's Inc.
CONN
| $1.28M | ﹤0.01% |
65,654
-504
| -0.8% | -$7.43K |
|
2094
Surgery Partners
SGRY
$2.03B
| $1.27M | ﹤0.01% |
28,783
-475
| -2% | -$17.6K |
|
|
TPC
2095
Tutor Perini Cor
TPC
$5.21B
| $1.27M | ﹤0.01% |
67,165
-4,200
| -6% | -$71.1K |
|
2096
Karyopharm Therapeutics
KPTI
$48M
| $1.27M | ﹤0.01% |
8,062
-252
| -3% | -$53.1K |
|
2097
nLIGHT
LASR
$3.17B
| $1.27M | ﹤0.01% |
39,252
-2,330
| -6% | -$82.5K |
|
|
VCRA
2098
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $1.27M | ﹤0.01% |
32,977
-3,884
| -11% | -$167K |
|
2099
Bally's
BALY
$658M
| $1.26M | ﹤0.01% |
19,447
-1,343
| -6% | -$79.6K |
|
2100
Sotera Health
SHC
$5.38B
| $1.26M | ﹤0.01% |
+50,654
| New | +$1.34M |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, RhumbLine Advisers held 3,102 positions worth $73.6B, up 1.6% from $72.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
RhumbLine Advisers withdrew a net $3.6B in Q1 2021, closing 100 positions and reducing 2,114 holdings. Its most notable exit was Tiffany & Co., an estimated $26.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in NXP Semiconductors worth $42.7M.
- RhumbLine Advisers's largest Q1 2021 buy was NXP Semiconductors: 211,843 shares worth $42.7M.
- RhumbLine Advisers added most to International Flavors & Fragrances in Q1 2021, an estimated $27.4M increase.
- RhumbLine Advisers's biggest Q1 2021 reduction was Apple, cutting an estimated $269M.
- RhumbLine Advisers fully exited Tiffany & Co. in Q1 2021, selling an estimated $26.8M.
- RhumbLine Advisers's ten largest holdings make up 21% of its $73.6B portfolio in Q1 2021.
- RhumbLine Advisers opened 50 new positions and closed 100 in Q1 2021.
- RhumbLine Advisers's portfolio value rose 1.6% quarter-over-quarter to $73.6B.
Based on RhumbLine Advisers's 13F filing for Q1 2021, filed 6 May 2021.